Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Shares of CME Group, parent of the Chicago Mercantile Exchange, edged out the market in 2023. Director William R.

CME Stock Beat the S&P 500. One Director Bought Up Stock.

Coinbase

Robinhood

NVIDIA

Block

Five crypto-centric stocks in focus are: NVDA, COIN, CME, SQ, HOOD.

Buy Bitcoin on the Dip for Solid Returns: 5 Stocks in Focus

CHICAGO and NEW YORK and LONDON and HONG KONG and SINGAPORE and SYDNEY , Jan. 23, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, today announced their enhanced cross-margining arrangement has gone live, enabling capital efficiencies for clearing members that trade and clear both U.S. Treasury securities and CME Group Interest Rate futures. With the new arrangement implemented, eligible clearing members of CME Group and the Government Securities Division (GSD) of DTCC's Fixed Income Clearing Corporation (FICC) can now cross-margin an expanded suite of products, including CME Group SOFR futures, Ultra 10-Year U.S. Treasury Note futures and Ultra U.S. Treasury Bond futures, with FICC-cleared U.S. Treasury notes and bonds.

CME Group and DTCC Launch Enhanced Treasury Cross-Margining Arrangement, Enabling Capital Efficiencies for Clearing Members

CME Group's (CME) global presence, compelling product portfolio, focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

Here's Why CME Group (CME) Deserves a Spot in Your Portfolio

Hidden Road, the global credit network for institutions, has launched listed derivatives clearing, starting with CME Group products NEW YORK , Jan. 17, 2024 /PRNewswire/ -- Hidden Road, the global credit network for institutions, today announced that it has extended its credit intermediation, clearing and financing offerings to cover listed derivatives markets through the firm's U.S. entity, Hidden Road Partners CIV US LLC, a registered futures commission merchant (FCM). The listed derivatives business is starting with CME Clearing (NASDAQ: CME) as its first venue and will be expanding venue and clearinghouse coverage globally over the coming months.

Hidden Road Continues Expansion into Listed Derivatives Clearing

Cboe Global Markets

Intercontinental Exchange

MarketAxess Holdings

A compelling and diversified product portfolio helps drive revenues of Zacks Securities and Exchanges industry players.

5 Stocks to Watch From the Thriving Securities and Exchanges Industry

CME (CME) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -7.96% in 4 Weeks, Here's Why CME (CME) Looks Ripe for a Turnaround

Atmos Energy

Deckers Outdoor

Netflix

Meta Platforms (META), Deckers Outdoor (DECK), Netflix (NFLX), Atmos Energy (ATO) and CME Group (CME) could make great plays as the Q4 earnings season unfolds.

5 Stocks From the Favorite Sectors of This Earnings Season

LONDON and SINGAPORE , Jan. 10, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that average daily volume (ADV) outside the United States reached a record 6.8 million contracts in 2023, up 8% from 2022. This record was driven largely by growth in Equity Index and Interest Rate products, up 26% and 23% respectively.

CME Group International Average Daily Volume Reaches Record 6.8 Million Contracts in 2023, Up 8% from 2022

CHICAGO , Jan. 9, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will launch options on S&P 500 Annual Dividend Index futures on January 29, pending regulatory review. "Client demand for managing risk and seeking investment opportunities around dividend exposure has accelerated the growth of our listed and centrally cleared dividend futures," said Paul Woolman, Global Head of Equity Products at CME Group.

CME Group to Launch Options on S&P 500 Annual Dividend Index Futures on January 29

For the first time, traders will be able to express a view on where E-mini S&P 500 and E-mini Nasdaq-100 futures will settle at the end of every quarter and year CHICAGO , Jan. 9, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will launch event contracts with quarter- and year-end expiries for E-mini S&P 500 and E-mini Nasdaq-100 futures on January 29, pending regulatory review. The new longer-horizon contracts will provide market users with another unique opportunity to express their views on the direction of these equity indices.

CME Group to Launch Longer-Dated Event Contracts on January 29

Agilent Technologies

Apple

AbbVie

Accenture Plc

Automatic Data Processing

Amgen

Amazon

Air Products and Chemicals

Ares Capital

Alexandria Real Estate Equities

ASML Hld

AvalonBay Communities

Broadcom

Booz Allen Hamilton Hld

Brookfield Asset Management

Brookfield Renewable Partners

SPDR Bloomberg 1-3 Month T-Bill ETF

Brookfield Infrastructure

Blackrock Inc

Broadridge Financial

British American Tobacco

Blackstone Group

Carrier Global

Canadian National Railway Company

I express frustration with the constant negativity surrounding the idea that beating the market is impossible for the average investor. I share my personal success in beating the market in 2023, with a time-weighted return of 28.02%. I emphasize the importance of buying high-quality companies at fair prices and holding them for the long term, while also highlighting the power of compounding dividends.

How I Beat The Market Again In 2023

Interactive Brokers

We have narrowed our search to five crypto-centric stocks with strong potential for 2024. These are NVDA, IBKR, CME, SQ and COIN.

5 Crypto-Centric Stocks to Watch in 2024 After a Solid 2023

Highest Q4 and December ADV in company history Record annual ADV across interest rate, options and agricultural products Record annual ADV reached outside the U.S. CHICAGO , Jan. 3, 2024 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its full-year, Q4 and December 2023 market statistics, showing it reached a record average daily volume (ADV) of 24.4 million contracts during the year, an increase of 5% over 2022. Q4 ADV increased 17% to a record 25.5 million contracts and December ADV increased 20% to a record 23.0 million contracts.

CME Group Reports Record Annual ADV of 24.4 Million Contracts in 2023

iShares Russell 2000 ETF

JPMorgan Chase & Co

Morgan Stanley

Vanguard Value ETF

Nobody knows for sure what the stock market or the economy will do, but here are some of my predictions for the new year. I think stocks will outperform many investors' expectations, but there's a lot more to the story.

5 Bold Predictions for the Stock Market and More in 2024 -- And Why a Few Will Probably Be Wrong

Johnson & Johnson

Coca-Cola

Eli Lilly

Lockheed Martin

Novo Nordisk

Novartis

PepsiCo

Procter & Gamble

Roche Holding AG

Raytheon Technologies

SPDR S&P 500 ETF Trust

I review the stocks of five world-class companies that I am convinced will bring me closer to my ambitious goal of being able to fund my living expenses through dividends.

Your New Year's Resolution For 2024: Invest $10,000 In These 5 Stocks

CHICAGO , Dec. 20, 2023 /PRNewswire/ -- CME Group Inc. will announce earnings for the fourth quarter and full year of 2023 before the markets open on Wednesday, February 14, 2024. Written highlights for the quarter will be posted on the company's website at 6:00 a.m.

CME Group Inc. Announces Fourth-Quarter and Year-End 2023 Earnings Release, Conference Call

CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.

CME Group (CME) Stock Surges 27% YTD: More Upside Left?

CME Group's stock (NASDAQ NDAQ : CME) has gained 26% YTD, as compared to the 23% rise in the S&P500 over the same period. Further, at its current price of $211 per share, it is trading slightly below its fair value of $215 – Trefis' estimate for CME Group's valuation.

Up 26% YTD, What's Next For CME Group Stock?

CHICAGO , Dec. 19, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will expand its suite of short-term metals options to include Tuesday and Thursday expiries for Gold, Silver, and Copper, pending regulatory review. With the addition of these new Weekly contracts, scheduled to begin trading on January 22, 2024, option expiries will now be available every day of the business week, Monday through Friday.

CME Group to Expand Gold, Silver and Copper Short-Term Options Expiries

CHICAGO , Dec. 15, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will conduct its 2024 annual meeting of shareholders at 10:00 a.m. Central Time on Thursday, May 9, 2024.

CME Group Announces 2024 Annual Meeting Date

CHICAGO , Dec. 14, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that open interest in its deeply liquid SOFR complex set a new record of 60,435,467 contracts on December 12, including 48.3 million options contracts and 12.1 million futures contracts. Average daily volume (ADV) in SOFR futures and options this year also reached a record 5.1 million contracts.

CME Group SOFR Open Interest Surpasses Record 60 Million Contracts

CHICAGO and LONDON , Dec. 11, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that it will combine its two non-deliverable forward (NDF) liquidity pools on the EBS Market platform onto a single trading venue in October 2024, subject to regulatory approval. The combination will bring market participants across regulatory jurisdictions into a unified global trading environment, supporting improved market efficiency and enhancing EBS's role as the leading source of centralized liquidity and price discovery in NDFs.

CME Group to Create Unified Global NDF Trading Venue, Expanding Access and Enhancing Liquidity For Participants

News for CME Group Stock (CME)